当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析

山东药玻

(600529)

  

流通市值:190.52亿  总市值:190.52亿
流通股本:6.64亿   总股本:6.64亿

山东药玻(600529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.21亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益775446.87万元,未分配利润379879.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产958807.14万元,负债183360.27万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,267,462,044.574,982,198,167.783,673,747,350.742,422,366,308.98
营业总成本1,004,324,485.14,070,167,292.142,949,611,615.531,967,479,550.47
营业利润274,176,089.32916,366,868.92741,815,093.17465,594,043.23
利润总额274,287,781.03910,823,796.31730,947,599.11460,397,811.66
净利润220,789,398.54775,802,014.62614,234,124.5385,504,879.91
其他综合收益----
综合收益总额220,789,398.54775,802,014.62614,234,124.5385,504,879.91
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计5,738,693,082.835,545,605,960.055,356,088,463.325,500,500,045.65
非流动资产合计3,849,378,326.123,773,115,590.793,662,880,697.953,568,253,305.45
资产总计9,588,071,408.959,318,721,550.849,018,969,161.279,068,753,351.1
流动负债合计1,763,513,212.821,726,592,238.621,590,095,723.311,865,798,801.48
非流动负债合计70,089,448.7857,620,534.0553,781,535.9955,502,954.59
负债合计1,833,602,661.61,784,212,772.671,643,877,259.31,921,301,756.07
归属于母公司股东权益合计7,754,468,747.357,534,508,778.177,375,091,901.977,147,451,595.03
股东权益合计7,754,468,747.357,534,508,778.177,375,091,901.977,147,451,595.03
负债和股东权益合计9,588,071,408.959,318,721,550.849,018,969,161.279,068,753,351.1
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,298,232,790.894,801,142,083.683,380,687,417.82,188,155,117.5
经营活动现金流出小计1,002,056,183.243,753,159,114.292,653,304,812.341,771,917,833.85
经营活动产生的现金流量净额296,176,607.651,047,982,969.39727,382,605.46416,237,283.65
投资活动现金流入小计1,220,157,795.455,448,963,747.263,776,990,140.612,619,949,511.37
投资活动现金流出小计1,646,350,674.026,193,530,465.754,550,003,127.153,426,507,163.36
投资活动产生的现金流量净额-426,192,878.57-744,566,718.49-773,012,986.54-806,557,651.99
筹资活动现金流入小计-12,464,854.8211,050,988.9411,050,988.94
筹资活动现金流出小计-199,084,233.9199,084,233.9-
筹资活动产生的现金流量净额--186,619,379.08-188,033,244.9611,050,988.94
汇率变动对现金及现金等价物的影响5,065,676.059,685,738.567,446,015.615,708,219.09
现金及现金等价物净增加额-124,950,594.87126,482,610.38-226,217,610.43-373,561,160.31
期末现金及现金等价物余额1,161,950,132.811,286,900,727.68934,200,506.87786,856,956.99
最新报告期:2024-04-23
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国联证券武慧东1.501.802.302024-04-23
中金公司陈彦,龚晴,杨茂达1.541.85--2024-04-23
民生证券李阳1.581.822.102024-04-23
天风证券杨松,王涛,林晓龙,鲍荣富1.521.872.212024-04-23
国泰君安杨冬庭,鲍雁辛1.511.772.032024-04-23
TOP↑